Lahoud Touma; Kristian B. Filion, PhD; Lee H. Sterling; et al.
free access
JAMA Neurol. 2016;73(3):275-281. doi:10.1001/jamaneurol.2015.4441
This meta-analysis of randomized clinical trials aims to quantify the benefits and risks of using stent retrievers in addition to recombinant tissue plasminogen activator for the treatment of acute ischemic stroke.
Rebekah M. Ahmed, MBBS; Muireann Irish, PhD; Elana Henning, BSc; et al.
free access
JAMA Neurol. 2016;73(3):282-290. doi:10.1001/jamaneurol.2015.4478
This study defines the severity of abnormal eating behavior and sucrose preference and associated neural networks in patients with behavioral variant frontotemporal dementia and semantic dementia.
Carl E. Clarke, MD; Smitaa Patel, MSc; Natalie Ives, MSc; et al.
free access
JAMA Neurol. 2016;73(3):291-299. doi:10.1001/jamaneurol.2015.4452
This randomized clinical trial aims to evaluate the clinical effectiveness of individualized physiotherapy and occupational therapy in Parkinson disease.
Hooi-Ling Teoh, MBBS; Shekeeb S. Mohammad, FRACP; Philip N. Britton, FRACP; et al.
free access
JAMA Neurol. 2016;73(3):300-307. doi:10.1001/jamaneurol.2015.4388
This prospective study of 61 children with enterovirus-related neurological disease during a 2013 outbreak in Sydney, Australia, further characterizes enterovirus 71 disease and outcomes in children.
Michael F. Waters, MD, PhD; Brian L. Hoh, MD; Michael J. Lynn, MS; et al.
free access
JAMA Neurol. 2016;73(3):308-315. doi:10.1001/jamaneurol.2015.4315
This post hoc analysis of a randomized clinical trial aims to determine baseline features that were associated with a high rate of the primary end point in the medical arm of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.
Sandeep Kumar, MD; Magdy Selim, MD, PhD; Sarah Marchina, PhD; et al.
free access
JAMA Neurol. 2016;73(3):316-320. doi:10.1001/jamaneurol.2015.4202
This case series describes the clinical presentation, neuroimaging findings, and outcomes of 17 patients with intracerebral hemorrhage and transient neurological signs and symptoms.
Anne-Marie A. Wills, MD, MPH; Adriana Pérez, PhD; Jue Wang, MS; et al.
free access
JAMA Neurol. 2016;73(3):321-328. doi:10.1001/jamaneurol.2015.4265
This secondary analysis of the NET-PD LS-1 reports on the association between change in body mass index, Unified Parkinson’s Disease Rating Scale scores, and survival among persons with Parkinson disease.
Yvonne L. Eaglehouse, PhD, MPH; Evelyn O. Talbott, DrPH; Yuefang Chang, PhD; et al.
free access
JAMA Neurol. 2016;73(3):329-336. doi:10.1001/jamaneurol.2015.4487
This cohort study uses data from the Women’s Health Initiative to evaluate whether physical activity is associated with risk of death from amyotrophic lateral sclerosis among postmenopausal women.
Panayiota Petrou, MD; Yael Gothelf, PhD; Zohar Argov, MD; et al.
free access
JAMA Neurol. 2016;73(3):337-344. doi:10.1001/jamaneurol.2015.4321
These 2 open-label proof-of-concept studies aim to determine the safety and possible clinical efficacy of autologous mesenchymal stem cell–neurotrophic growth factor cell transplantation in patients with amyotrophic lateral sclerosis.